Back to Journals » International Journal of Nanomedicine » Volume 12

RETRACTED ARTICLE: Gold nanoparticles enhance TRAIL sensitivity through Drp1-mediated apoptotic and autophagic mitochondrial fission in NSCLC cells
Authors Ke S, Zhou T, Yang P, Wang Y , Zhang P, Chen K, Ren L, Ye S
Received 2 December 2016
Accepted for publication 28 February 2017
Published 31 March 2017 Volume 2017:12 Pages 2531—2551
DOI https://doi.org/10.2147/IJN.S129274
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Professor Lei Yang
This paper has been retracted.
Ke S, Zhou T, Yang P, et al. Int J Nanomedicine. 2017;12:2531—2551.
We, the authors and Publisher of the journal International Journal of Nanomedicine, are retracting the published article.
Since publication, concerns have been raised by a third party about the integrity of the western blot data in the article. When approached for an explanation, the authors were unable to provide the original data and requested the retraction of this article. Additionally, the journal was made aware of concerns regarding the authorship of this article but have been unable to verify these concerns. When contacted for further clarification, the authors did not respond. The corresponding author has been informed of this retraction.
We have been informed in our decision-making by our editorial policies and the COPE guidelines. The retracted articles will remain online to maintain the scholarly record, but they will be digitally watermarked on each page as “Retracted”.
© 2017 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.